Serial metabolic profiling and liver transplantation in concurrent maple syrup urine disease and type 1 diabetes.
4 affiliations
- 1Department of Medicine, Division of Endocrinology and Metabolism, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.
- 2Department of Pediatrics, Division of Pediatric Genetics and Metabolism, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.
- 3Department of Pediatrics, Division of Medical Genetics, Duke University, Durham, NC 27710, USA.
- 4Biochemical Genetics Laboratory, Duke University Health System, Durham, NC 27713, USA.
Abstract
Maple syrup urine disease (MSUD) and type 1 diabetes (T1D) require careful attention to dietary composition and predispose to ketoacidosis. The co-occurrence of these metabolic disorders therefore compounds these challenges. Here, we present a 29-year-old man with prenatally diagnosed MSUD and childhood-onset T1D who, despite extreme metabolic vulnerability, did well until his mid-20s, when he was admitted to the hospital 8 times for metabolic decompensation, with the latter 7 times occurring within a 12-month period. Most laboratory evaluations were suggestive of MSUD crisis rather than diabetic ketoacidosis. Ultimately, the patient underwent liver transplantation for definitive treatment of MSUD. The case illustrates the complexity of comanaging T1D with an inborn error of metabolism requiring dietary modification that challenges glycemic management.
Related
- Development and validation of a novel metabolic-inflammatory health-related nomogram for predicting in-hospital mortality in older patients with type 2 diabetes mellitus combined with cardiovascular disease
- Speckle Tracking Analysis of the Left and Right Heart in Type 1 Diabetes Patients with End-Stage Renal Disease Awaiting Simultaneous Pancreas-Kidney Transplantation.
- Comparison of Metabolic Dysfunction‐Associated Steatotic Liver Disease Between Individuals With Werner Syndrome and Those With Insulin‐Resistant Type 2 Diabetes: Hepatic Steatosis and Fibrosis Indices
- Blood DNA methylation profiling identifies candidate diabetic kidney disease risk signatures in the PROPHECY Aboriginal Diabetes Study
- Targeting Gut Microbiota, Inflammation, and Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus: Therapeutic Strategies and the Emerging Role of Time-Restricted Feeding
BibTeX
@article{wang2026serial,
title = {{Serial metabolic profiling and liver transplantation in concurrent maple syrup urine disease and type 1 diabetes.}},
author = {Eileen Y Wang and G Stephen DeCherney and Michael C Adams and Ashlee R Stiles and Monika Williams and Brooke C Matson},
journal = {JCEM case reports},
year = {2026},
month = nov,
doi = {10.1210/jcemcr/luag344},
url = {https://europepmc.org/article/MED/42996828},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Serial metabolic profiling and liver transplantation in concurrent maple syrup urine disease and type 1 diabetes.
AU - Eileen Y Wang
AU - G Stephen DeCherney
AU - Michael C Adams
AU - Ashlee R Stiles
AU - Monika Williams
AU - Brooke C Matson
PY - 2026
DA - 2026/11/06
JO - JCEM case reports
DO - 10.1210/jcemcr/luag344
UR - https://europepmc.org/article/MED/42996828
AB - Maple syrup urine disease (MSUD) and type 1 diabetes (T1D) require careful attention to dietary composition and predispose to ketoacidosis. The co-occurrence of these metabolic disorders therefore compounds these challenges. Here, we present a 29-year-old man with prenatally diagnosed MSUD and childhood-onset T1D who, despite extreme metabolic vulnerability, did well until his mid-20s, when he was admitted to the hospital 8 times for metabolic decompensation, with the latter 7 times occurring within a 12-month period. Most laboratory evaluations were suggestive of MSUD crisis rather than diabetic ketoacidosis. Ultimately, the patient underwent liver transplantation for definitive treatment of MSUD. The case illustrates the complexity of comanaging T1D with an inborn error of metabolism requiring dietary modification that challenges glycemic management.
SN - 2755-1520
ER -